Teva Pharmaceutical Industries Ltd., a leading generic pharmaceutical company, (NYSE and TASE: TEVA) announced today that it is working with Honeywell (NASDAQ: HON) to help reduce energy consumption and carbon emissions at its Debrecen, Hungary, manufacturing facility.
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model, enabling it to deploy energy improvement upgrades without making a major capital investment. The efforts will support Teva furthering its environmental, social and governance goals and minimize its impact on the environment.
